ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AMLX Amylyx Pharmaceuticals Inc

4.035
0.075 (1.89%)
Last Updated: 18:22:42
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 21.89M71.43M98.22M102.69M108.45M88.64M-1.02M0
Operating Income -44.59M-2.05M20.2M18.72M1.93M-11.67M-68.88M60.48M
Pre Tax Income -42.13M1.4M24.01M22.41M6.48M-118.55M-72.7M-72.95M
Net Income -42.7M1.57M22.07M20.89M4.73M-118.79M-72.7M-72.7M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -44.59M-2.32M20.2M17.89M1.93M-12.42M-69.36M-202.49M
EBITDA -44.41M-1.85M20.48M19.02M2.24M-11.35M-68.67M59.96M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.43M1.43M285k22.23M380.79M
Operating Income -13.55M-13.55M-82.69M-201.34M38.8M
Pre Tax Income -13.72M-13.72M-87.93M-197.6M54.3M
Net Income -13.72M-13.72M-87.93M-198.38M49.27M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -2.288-2.288-3.162-2.2720.558
EBIT -13.56M-13.56M-82.74M-201.34M38.8M
EBITDA -13.55M-13.55M-82.64M-200.85M39.89M

Your Recent History

Delayed Upgrade Clock